Covid-19 Drug | The Business Standard

Covid-19 Drug

Covid-19 Drug

Life-saving Covid drug identified

Life-saving Covid drug identified

FILE PHOTO: The headquarters of the US Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed

US FDA lifts clinical hold on Inovio's Covid-19 vaccine trial

India's Everest Organics starts making ingredient for Merck's Covid-19 pill

Merck begins late-stage trial of experimental Covid-19 drug

Flag of the European Union/Collected

EU signs deal with GSK for supply of Covid potential drug

Five Indian drugmakers to jointly start local trial of Merck & Co's Covid-19 drug

Study confirms GSK-Vir antibody drug reduces hospitalisation, death in Covid-19 patients

Mortuary workers load the body of a person, who died from the coronavirus disease (Covid-19), to an ambulance for cremation, at a Hospital in New Delhi, India May 5, 2021. REUTERS/Adnan Abidi

Mukesh Ambani's reliance explores tapeworm drug for Covid-19

Merck says study shows Covid-19 drug causes quick reduction in virus

European Union flags fly outside the EU Commission headquarters in Brussels, Belgium September 19, 2019/ Reuters

EU buys limited supply of Covid drug remdesivir, seeks more

FILE PHOTO: Workers clean the windows of a building of Roche in Rotkreuz May 27, 2020. REUTERS/Arnd Wiegmann

Roche bid to retool arthritis drug for Covid-19 fails

The ultrastructural morphology exhibited by the 2019 Novel Coronavirus, which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, US January 29, 2020/Reuters

New study on coronavirus molecules may lead to drug development

From left: Southampton professors Ratko Djukanovic, Donna Davies and Stephen Holgate, founded Synairgen decades ago after finding patients’ defences against viruses could be boosted if a missing protein were replaced. Picture: Collected

A breakthrough in Covid-19 drug makes 3 UK professors millionaires